| Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors Y Numan, Z Abdel Rahman, J Grenet, S Boisclair, JP Bewersdorf, ... American journal of hematology 97 (3), 322-328, 2022 | 25 | 2022 |
| Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study Y Alkhatib, Z Abdel Rahman, P Kuriakose Leukemia & lymphoma 58 (5), 1130-1134, 2017 | 17 | 2017 |
| Impact of novel targeted therapies and cytogenetic risk groups on outcome after allogeneic transplantation for adult ALL ZHA Rahman, MG Heckman, K Miller, H Alkhateeb, MS Patnaik, ... Transplantation and Cellular Therapy 27 (2), 165. e1-165. e11, 2021 | 11 | 2021 |
| Comparative study of therapy‐related and de novo adult b‐cell acute lymphoblastic leukaemia ZH Abdel Rahman, RD Parrondo, MG Heckman, M Wieczorek, KC Miller, ... British journal of haematology 196 (4), 963-968, 2022 | 8 | 2022 |
| Preliminary results of a randomized trial comparing intensive chemotherapy with growth factor (gf) for peripheral blood progenitor (pbpc) cell mobillization to growth factor … J Gajewski, N Mirza, R Mehra, R Saliba, J Bruton, Z Rahman Experimental hematology 26 (8), 1998 | 8 | 1998 |
| Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma RD Parrondo, ZA Rahman, MG Heckman, M Wieczorek, L Jiang, ... Blood cancer journal 12 (6), 87, 2022 | 7 | 2022 |
| Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS) JL Saw, MH Sidiqi, M Ruff, S Hocker, H Alkhateeb, SM Ansell, ... Blood cancer journal 12 (4), 62, 2022 | 6 | 2022 |
| C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel M Melody, ZA Rahman, H Saunders, PL Diaz, N Gannon, A Rosenthal, ... Hematology/Oncology and Stem Cell Therapy 14 (2), 141-146, 2021 | 6 | 2021 |
| A case of false-positive Mycobacterium tuberculosis caused by Mycobacterium celatum E Gildeh, Z Abdel-Rahman, R Sengupta, L Johnson Case Reports in Infectious Diseases 2016, 2016 | 6 | 2016 |
| Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience M Melody, S Gandhi, H Saunders, Z Abdel-Rahman, J Hastings, ... Leukemia & Lymphoma 63 (6), 1363-1368, 2022 | 5 | 2022 |
| Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes ZH Abdel-Rahman, MG Heckman, T Anagnostou, LJ White, ... Blood cancer journal 11 (9), 156, 2021 | 5 | 2021 |
| Hairy cell leukemia with CCND1/IGH fusion gene and BRAF V600E mutation ZA Rahman, F Muwalla, L Jiang, J Foran Leukemia Research Reports 13, 100197, 2020 | 5 | 2020 |
| Intensity of cancer care near the end of life at a tertiary care cancer center in Jordan H Abdel-Razeq, O Shamieh, M Abu-Nasser, M Nassar, Y Samhouri, ... Journal of pain and symptom management 57 (6), 1106-1113, 2019 | 5 | 2019 |
| Predictors and management of relapse to Axicabtagene Ciloleucel in patients with aggressive B-cell lymphoma JV Forero-Forero, PA Lengerke-Diaz, E Moreno-Cortes, M Melody, ... Hematology/Oncology and Stem Cell Therapy, 2021 | 4 | 2021 |
| Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel M Melody, S Gandhi, ZA Rahman, P Lengerke‐Diaz, N Gannon, ... European Journal of Haematology 107 (1), 48-53, 2021 | 4 | 2021 |
| Plasmapheresis and myeloma cast nephropathy: a meta-analysis and review of evidence Y Alkhatib, A Dadla, D Malik, Z Abdel-Rahman, P Kuriakose, VS Dabak, ... Blood 130, 5415, 2017 | 3 | 2017 |
| Adult Philadelphia-like B-cell acute lymphoblastic leukemia: Characteristics, outcomes, and role of allogeneic hematopoietic cell transplantation in comparison to Philadelphia … Z Abdel Rahman, M Heckman, T Anagnostou, L White, SM Kloft-Nelson, ... Journal of Clinical Oncology 39 (15_suppl), 7022-7022, 2021 | 2 | 2021 |
| Outcomes of patients with thrombocytopenia evaluated at hematology subspecialty clinics ZHA Rahman, KC Miller, H Jabbour, Y Alkhatib, V Donthireddy Hematology/oncology and stem cell therapy, 2021 | 2 | 2021 |
| Risk of thrombosis in CAR T-cell therapy recipients M Melody, S Gandhi, H Saunders, Z Abdel-Rahman, J Hastings, PL Diaz, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | 2 | 2021 |
| Gilteritinib remains clinically active in relapsed/refractory FLT3 mutated AML previously treated with FLT3 inhibitors Y Numan, ZA Rahman, J Grenet, S Boisclair, JP Bewersdorf, D Barth, ... Blood 136, 5-7, 2020 | 2 | 2020 |
HEMANT MURTHYMayo Clinic FloridaVerified email at MAYO.EDU
